Neuro-regenerative effect of autologous mesenchymal stem cell therapy in cerebral palsy patients: pilot clinical trial

      Stem cell-based therapies provide hope for various CNS diseases including perinatal hypoxic ischemic insults of the brain. Stem cells have the capacity to proliferate in culture, migrate and disseminate following implantation within the adult CNS. The neuroregenerative potential of bone marrow-derived mesenchymal stem cells (MSCs) is proposed to be through paracrine effect, stimulation of endogenous stem cells, angiogenesis, in addition to the disputed possibility of direct transdifferentiation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect